Bonnie Anderson is the cofounder and Chief Executive Officer of Veracyte, formed in 2008. Her career spans more than 25 years in regulated diagnostics and life science markets where she has led both early-stage businesses as well as mature, global enterprises. Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter, including heading the company's global cellular analysis franchises in hematology and flow cytomatery. As Vice President of the intrapreneurial start-up Immunomics Operations, she successfully positioned the company's novel MHC tetramer technology as a vehicle for drug and vaccine developers to monitor ex-vivo immune response. She currently serves on the advisory board for Bay Bio. She has also served on the boards of Thymed, GmbH and Women in Biotechnology.